Page 4 - Germline Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) INDIANAPOLIS (dpa-AFX) - Today's Daily Dose brings you news about the effectiveness of Lilly's Bamlanivimab in reducing the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, executive changes at BiondVax Pharma, regulatory update on Genetic Technologies' COVID-19 PRS Test, Adamis' SYMJEPI products being made available in the Walgreens Prescription Savings Club, Fluidigm's Advanta Dx SARS-CoV-2 RT-PCR Assay receiving the CE-IVD mark. Read on. 1. Adamis to Offer SYMJEPI in Walgreens Prescription Savings Club Adamis Pharmaceuticals Corporation (...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion ... Genetic Technologies LtdJanuary 21, 2021 GMT MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on further development on the COVID-19 serious disease risk Polygenic Risk Score Test (COVID-19 PRS Test) and expansion of the Company’s offering to include Ge...